AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published September 12, 2009
This Article
Free to Access This article has been Unlocked
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Aboul-Enein, F.
Right arrow Articles by Kristoferitsch, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aboul-Enein, F.
Right arrow Articles by Kristoferitsch, W.

American Journal of Neuroradiology
DOI 10.3174/ajnr.A1791

BRAIN

Diffuse White Matter Damage Is Absent in Neuromyelitis Optica

F. Aboul-Enein, M. Krssák, R. Höftberger, D. Prayer and W. Kristoferitsch

From the Department of Neurology (F.A.-E., W.K.), SMZ-Ost Donauspital, Vienna, Austria; and Department of Radiology (M.K., D.P.) and Institute of Neurology (R.H.), Medical University of Vienna, Vienna, Austria.

Please address correspondence to Fahmy Aboul-Enein, MD, Department of Neurology, SMZ-Ost Donauspital, Langobardenstr 122, A-1220, Vienna, Austria; e-mail: fahmy.aboul-enein{at}chello.at

BACKGROUND AND PURPOSE: Neuromyelitis optica (NMO) is an idiopathic mostly relapsing inflammatory disease with attacks on the optic nerves and spinal cord. Whether NMO is a separate disease or a subtype of classic multiple sclerosis (MS) is unclear. Clinically, CSF and MR imaging parameters and histopathologic data suggest that the normal-appearing white matter (NAWM) may be affected in MS but not in patients with NMO. Therefore, we hypothesized that the NAWM in NMO is normal.

MATERIAL AND METHODS: We studied prospectively 8 patients with clinically definitive NMO or remitting longitudinal extensive transverse myelitis (LETM) and 8 healthy controls. Ratios of N-acetylaspartate to creatine (Cr) and choline to Cr and the absolute concentrations of the metabolites were measured by chemical shift imaging with a 1H-MR spectroscopy operating at 3T. All patients with clinically definitive NMO and LETM were found to be positive for NMO–immunoglobin G with a commercially available test.

RESULTS: The metabolic pattern of the NAWM of patients with NMO showed no difference compared with age- and sex-matched healthy controls.

CONCLUSIONS: Diffuse white matter damage is absent in NMO.






Copyright © 2009 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X